---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-100638"
form_type: "8-K"
ticker: "GILD"
cik: "0000882095"
company_name: "GILEAD SCIENCES, INC."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T18:19:17.713285+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Gilead issues $2B in senior notes: $1B at 5.25% due 2033, $1B at 5.55% due 2053

## Summary
- Issued $1,000,000,000 aggregate principal of 5.250% Senior Notes due 2033.
- Issued $1,000,000,000 aggregate principal of 5.550% Senior Notes due 2053.
- Net proceeds will be used for general corporate purposes.
- Underwriting agreement entered with Barclays Capital Inc. and Citigroup Global Markets Inc.

## SEC filing metadata
- accession: 0001104659-23-100638
- form_type: 8-K
- ticker: GILD
- cik: 0000882095
- company_name: GILEAD SCIENCES, INC.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882095/000110465923100638/0001104659-23-100638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882095/000110465923100638/tm2324696d5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-100638
- JSON: https://secwatch.observer/filing/0001104659-23-100638.json
- Plain text: https://secwatch.observer/filing/0001104659-23-100638.txt

## Key facts
- Debt Financings
  GILEAD SCIENCES, INC. incurred senior notes of $1,000,000,000 aggregate principal amount of the Company's 5.250% Senior Notes due 2033 and $1,000,000,000 aggregate pri with Computershare Trust Company, National Association at 5.250% per annum on the 2033 Notes and 5.550% per annum on the 2053 Notes maturing October 15, 2033 for the 2033 Notes and October 15, 2053 for the 2053 Notes.
  - Instrument: senior notes
  - Principal: $1,000,000,000 aggregate principal amount of the Company's 5.250% Senior Notes due 2033 and $1,000,000,000 aggregate pri
  - Counterparty: Computershare Trust Company, National Association
  - Rate: 5.250% per annum on the 2033 Notes and 5.550% per annum on the 2053 Notes
  - Maturity: October 15, 2033 for the 2033 Notes and October 15, 2053 for the 2053 Notes
  - Event: incurrence
  source text: The Ninth Supplemental Indenture relates to the Company's issuance of (a) $1,000,000,000 aggregate principal amount of the Company's 5.250% Senior Notes due 2033 (the "2033 Notes") and (b) $1,000,000,000 aggregate principal amount of the Company's 5.550% Senior Notes due 2053 (the "2053 Notes" and, together with the 2033 Notes, the "Notes").
  evidence_url: https://www.sec.gov/Archives/edgar/data/882095/000110465923100638/0001104659-23-100638-index.htm
- Material Agreements
  GILEAD SCIENCES, INC. entered into Ninth Supplemental Indenture with Computershare Trust Company, National Association valued at $1,000,000,000 aggregate principal amount of the Company's 5.250% Senior Notes due 2033 and $1,000,0 (effective 2023-09-14).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: Computershare Trust Company, National Association
  - Value: $1,000,000,000 aggregate principal amount of the Company's 5.250% Senior Notes due 2033 and $1,000,0
  - Effective: 2023-09-14
  source text: On September 14, 2023, Gilead Sciences, Inc. (the “Company”) and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as trustee (the “Trustee” and, together with the Company, the “Parties”), entered into a Ninth Supplemental Indenture (the “Ninth Supplemental Indenture”) to the Indenture between the Parties, dated as of March 30, 2011 (the “Base Indenture”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/882095/000110465923100638/0001104659-23-100638-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.